首页> 外国专利> Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1h-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-indazol-5-yloxy) benzyl) urea hydrochloride

Crystalline forms of 1-(3-tert-butyl-1-p-tolyl-1h-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-indazol-5-yloxy) benzyl) urea hydrochloride

机译:1-(3-叔丁基-1-对甲苯基-1h-吡唑-5-基)-3-(5-氟-2-(1-(2-羟乙基)-吲唑-5-基氧基)的晶体形式)苄基)盐酸尿素

摘要

Provided herein is a hydrogen chloride salt of 1-(3-/t?r/-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea, crystalline forms of 1-(3-½^butyl-1^-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea hydrochloride, processes for the preparation of said crystalline forms, pharmaceutical compositions containing a crystalline form of 1-(3-ri/-r-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(5-fluoro-2-(1-(2-hydroxyethyl)-1H-indazol-5-yloxy)benzyl)urea hydrochloride Form B, processes for the preparation of said compositions, pharmaceutical compositions prepared by said methods, and the use of said compositions in the treatment of various diseases and disorders.
机译:本文提供的是1-(3- /叔丁基/ -1-丁基-对甲苯基-1H-吡唑-5-基)-3-(5-氟-2-(1-(2 -羟乙基)-1H-吲唑-5-基氧基)苄基)脲,1-(3-½^丁基-1 ^-甲苯基-1H-吡唑-5-基)-3-(5-氟-2 -(1-(2-羟乙基)-1H-吲唑-5-基氧基)苄基)脲盐酸盐,所述晶型的制备方法,含有1-(3-r <i / -r)晶型的药物组合物-丁基-1-对甲苯基-1H-吡唑-5-基)-3-(5-氟-2-(1-(2-羟乙基)-1H-吲唑-5-基氧基)苄基)脲盐酸盐B型,用于制备所述组合物的方法,通过所述方法制备的药物组合物,以及所述组合物在治疗各种疾病和病症中的用途。

著录项

  • 公开/公告号IL234192A

    专利类型

  • 公开/公告日2019-11-28

    原文格式PDF

  • 申请/专利权人 ARRAY BIOPHARMA INC.;

    申请/专利号IL20140234192

  • 发明设计人

    申请日2014-08-19

  • 分类号A61K31/4155;A61P35;

  • 国家 IL

  • 入库时间 2022-08-21 11:17:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号